z-logo
Premium
Compound Seropositivity of neutralizing antibodies against Adipogenic Adenoviruses (ADV36+ and ADV 37+): no additive effect on overweight‐obesity and on Insulin Resistance (IRHOMA). The microbiome across the obesity and into the liver
Author(s) -
Trovato Guglielmo M.,
Catalano Daniela,
Martines G. Fabio,
Trovato Francesca M.,
Garozzo Adriana,
Pirri Clara,
Tonzuso Antonia
Publication year - 2013
Publication title -
the faseb journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.709
H-Index - 277
eISSN - 1530-6860
pISSN - 0892-6638
DOI - 10.1096/fasebj.27.1_supplement.1056.4
Subject(s) - medicine , obesity , insulin resistance , overweight , endocrinology , gastroenterology
A greater hazard of obesity and Insulin Resistance is associated with ADV36 adenovirus seropositivity (ADV36+). Human ADV37 has steatogenic liver effects in humans, but adipogenic effect only in animals: ADV37+patients do not show greater prevalence of obesity vs. ADV37/ADV36 seronegative subjects. Aim to investigate if compound ADV36/ADV37 seropositivity exerts a different effect on overweight‐obesity and IR vs. seronegative subjects and vs. ADV36‐ADV37 single seropositivity. 430 patients were studied, m 157, f 273, age 47.99 ± 15.50 years, BMI 28.14 ± 6.29. Dietary profile was assessed by Adherence to Mediterranean Diet Score (AMDS). Greater BMI (29.74 ± 7.21 vs. 26.47 ± 5.32;p: 0.004) and no difference for HOMA (2.42 ± 1.38 VS 2.28 ± 1.38; p: 0.591) are observed in ADV36+ subjects vs. ADV37+. Compound ADV36+/ADV37+ vs. ADV37+ lone seropositivity has greater BMI: 29.42 ± 6.13 vs. 26.47 ± 5.32; p: 0.001 and greater HOMA: 2.94 ± 2.31 vs. 2.28 ± 1.38; p: 0.029, exactly as the compound seropositivity vs. totally seronegative subjects: BMI: 29.42 ± 6.13 vs. 26.41 ± 5.99; p: 0.0001; HOMA: 2.94 ± 2.31 vs. 2.07 ± 1.39; p: 0.0001; no difference for compound seropositivity ADV36+/ADV37+ vs. ADV36+ lone group. No difference of AMDS was observed between any group. Conclusion ADV36+ and ADV37+ compound seropositivity, independently by difference of nutritional profile, has no additive effect for obesity and insulin resistance.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here